IP Library Granted Patent US 7,531,693
Granted Patent B2
US 7,531,693 · App. 10/851,658 · Granted May 12, 2009

Lipids for transfection of nucleic acids

Assignee: Molecular Transfer, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,531,693
App. No.
10/851,658
Granted
May 12, 2009
Kind
B2
Abstract

Cationic lipid compositions are provided that are useful for efficient delivery of macromolecules, such as nucleic acids, into a wide variety of eukaryotic cell types. Methods for using the compositions also are provided.

Claims (69)

1. A lipid having the formula:

wherein X 1 is selected from the group consisting of (CH 2 ) n , (CHOH) n , —NH—, —O—, a polyether, an ester linkage —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC (═NH) NH,

Y 1 is selected from the group consisting of (CH 2 ) n , a polyether, NHCO, —CO—, and a polyamide,

Y 2 is selected from the group consisting of (CH 2 ) n , —NH—, —O—, a polyether, an ester linkage, —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC (═NH) NH,

Z 1 and Z 2 are independently selected from the group consisting of primary alkylamine, secondary alkylamine, tertiary alkyl amine, quaternary alkylamine, alkyl amino alcohol, alkyl polyamine, spermidine, spermine, carboxy spermine, guanidinium, pyridinium, pyrollidinium, piperidinyium amino acyl, peptidyl, and protein,

R 8 and R 9 are independently selected from the group consisting of straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC (═NH) NH],

R 10 and R 11 are independently absent or selected from the group consisting of hydrogen, straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC (═NH) NH], and

n=1-12.

2. A lipid according to claim 1 , wherein R 8 and R 9 are independently selected from the group consisting of straight chain C 1 -C 20 alkyl and branched alkyl.

3. A lipid according to claim 1 wherein X 1 is (CHOH) n .

4. A composition comprising a lipid and a macromolecule, wherein said lipid has the formula:

wherein X 1 is selected from the group consisting of (CH 2 ) n , (CHOH) n , —NH—, —O—, a polyether, an ester linkage —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC (═NH) NH,

Y 1 is selected from the group consisting of (CH 2 ) n , a polyether, NHCO, —CO—, and a polyamide,

Y 2 is selected from the group consisting of (CH 2 ) n , —NH—, —O—, a polyether, an ester linkage, —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC (═NH) NH,

Z 1 and Z 2 are independently selected from the group consisting of primary alkylamine, secondary alkylamine, tertiary alkyl amine, quaternary alkylamine, alkyl amino alcohol, alkyl polyamine, spermidine, spermine, carboxy spermine, guanidinium, pyridinium, pyrollidinium, piperidinyium amino acyl, peptidyl, and protein,

R 8 and R 9 are independently selected from the group consisting of straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC (═NH) NH],

R 10 and R 11 are independently absent or selected from the group consisting of hydrogen, straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC (═NH) NH], and

n=1-12.

5. The composition according to claim 4 wherein said macromolecule is a peptide, protein or a nucleic acid.

6. The composition according to claim 5 wherein said macromolecule is a nucleic acid.

7. The composition according to claim 6 , wherein said nucleic acid comprises a DNA molecule.

8. The composition according to claim 7 , wherein said DNA molecule is a double stranded DNA molecule.

9. The composition according to claim 8 , wherein said DNA molecule is a plasmid.

10. The composition according to claim 9 , wherein said plasmid encodes an RNA molecule that is self complementary and that forms a region of double stranded RNA.

11. The composition according to claim 6 , wherein said nucleic acid comprises an RNA molecule.

12. The composition according to claim 11 , wherein said RNA molecule is a double stranded RNA molecule.

13. The composition according to claim 12 , wherein said RNA molecule is an siRNA.

14. A method of introducing a macromolecule into a cell, comprising contacting a eukaryotic cell with a composition comprising a lipid and a macromolecule, wherein said lipid has the formula:

wherein X 1 is selected from the group consisting of (CH 2 ) n , (CHOH) n , —NH—, —O—, a polyether, an ester linkage —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC (═NH) NH,

Y 1 is selected from the group consisting of (CH 2 ) n , a polyether, NHCO, —CO—, and a polyamide,

Y 2 is selected from the group consisting of (CH 2 ) n , —NH—, —O—, a polyether, an ester linkage, —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC (═NH) NH,

Z 1 and Z 2 are independently selected from the group consisting of primary alkylamine, secondary alkylamine, tertiary alkyl amine, quaternary alkylamine, alkyl amino alcohol, alkyl polyamine, spermidine, spermine, carboxy spermine, guanidinium, pyridinium, pyrollidinium, piperidinyium amino acyl, peptidyl, and protein,

R 8 and R 9 are independently selected from the group consisting of straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC (═NH) NH],

R 10 and R 11 are independently absent or selected from the group consisting of hydrogen, straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC (═NH) NH], and

n=1-12.

15. A composition according to claim 5 wherein said macromolecule is a peptide or protein.

16. A method according to claim 14 , wherein said macromolecule is a nucleic acid.

17. A method according to claim 14 , wherein said macromolecule is a peptide or protein.

18. A method of introducing a desired molecule into a tissue, comprising contacting said tissue with a composition comprising said desired molecule and a lipid, wherein said lipid has the formula:

wherein X 1 is selected from the group consisting of (CH 2 ) n , (CHOH) n , —NH—, —O—, a polyether, an ester linkage —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC (═NH) NH,

Y 1 is selected from the group consisting of (CH 2 ) n , a polyether, NHCO, —CO—, and a polyamide,

Y 2 is selected from the group consisting of (CH 2 ) n , —NH—, —O—, a polyether, an ester linkage, —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC (═NH) NH,

Z 1 and Z 2 are independently selected from the group consisting of primary alkylamine, secondary alkylamine, tertiary alkyl amine, quaternary alkylamine, alkyl amino alcohol, alkyl polyamine, spermidine, spermine, carboxy spermine, guanidinium, pyridinium, pyrollidinium, piperidinyium amino acyl, peptidyl, and protein,

R 8 and R 9 are independently selected from the group consisting of straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC (═NH) NH],

R 10 and R 11 are independently absent or selected from the group consisting of hydrogen, straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC (═NH) NH], and

n=1-12.

19. The method according to claim 18 wherein said desired molecule is a peptide, protein, or nucleic acid.

20. A kit for transfecting a cell, comprising a lipid having the formula

wherein X 1 is selected from the group consisting of (CH 2 ) n , (CHOH) n , —NH—, —O—, a polyether, an ester linkage —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC (═NH) NH,

Y 1 is selected from the group consisting of (CH 2 ) n , a polyether, NHCO, —CO—, and a polyamide,

Y 2 is selected from the group consisting of (CH 2 ) n , —NH—, —O—, a polyether, an ester linkage, —S—, CONH, NHCO, a polyamide —NHCONH—, and NHC (═NH) NH,

Z 1 and Z 2 are independently selected from the group consisting of primary alkylamine, secondary alkylamine, tertiary alkyl amine, quaternary alkylamine, alkyl amino alcohol, alkyl polyamine, spermidine, spermine, carboxy spermine, guanidinium, pyridinium, pyrollidinium, piperidinyium amino acyl, peptidyl, and protein,

R 8 and R 9 are independently selected from the group consisting of straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC (═NH) NH],

R 10 and R 11 are independently absent or selected from the group consisting of hydrogen, straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, cyclo alkenyl, and optionally substituted aryl, wherein said optional substitution, when present, comprises at least one functional group selected from the group consisting of —OH, NH 2 , —COOH, ester, amide, alkylamino, —NHCONH—, and NHC (═NH) NH], and

n=1-12.

21. A lipid having the formula:

wherein X 1 is (CHOH) n ,

Y 1 is (CH 2 ) n ,

Y 2 is (CH 2 ) n ,

Z 1 and Z 2 are independently selected from the group consisting of primary alkylamine, secondary alkylamine, tertiary alkyl amine, quaternary alkylamine, alkyl amino alcohol, alkyl polyamine, spermidine, spermine, and carboxy spermine,

R 8 and R 9 are independently selected from the group consisting of straight chain C 1 -C 20 alkyl, branched alkyl, cycloalkyl, straight chain alkenyl, branched alkenyl, and cyclo alkenyl,

R 10 and R 11 are independently absent or hydrogen, and

n=1-12.

22. A lipid according to claim 21 , wherein Z 1 and Z 2 are independently selected from the group consisting of primary alkylamine, secondary alkylamine, tertiary alkyl amine, quaternary alkylamine, and alkyl amino alcohol.

23. A lipid according to claim 21 , wherein R 8 and R 9 are independently selected from the group consisting of straight chain C 1 -C 20 alkyl, and branched alkyl.

24. A lipid according to claim 21 , wherein R 8 is a long chain alkyl.

25. A composition comprising a lipid and a nucleic acid, wherein said lipid is a lipid according to claim 21 .

26. A method of introducing a nucleic acid into a cell, comprising contacting a eukaryotic cell with a composition comprising a lipid and said nucleic acid, wherein said lipid is a lipid according to claim 21 .

27. A method of introducing a nucleic acid into a tissue, comprising contacting said tissue with a composition comprising said nucleic acid and a lipid, wherein said lipid is a lipid according to claim 21 .

Assignments (3)
SECURITY AGREEMENT Recorded Jan 30, 2014
From: MOLECULAR TRANSFER, INC.
To: THOMPSON AND PATRICIA A THOMPSON AS TRUSTEES OF THE THOMPSON FAMILY TRUST DATED AUGUST 27 2002, JOHN D.; THOMPSON, PATRICK R.; BIOTECH INVESTMENT GROUP LLC
Reel/Frame 032138/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2005
From: GEBEYEHU, GULILAT
To: MOLECULAR TRANSFER, INC.
Reel/Frame 016240/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2004
From: GEBEYEHU, GULILAT; JAOUNI, TAYSIR M.; JESSEE, JOEL
To: MOLECULAR TRANSFER, INC.
Reel/Frame 015798/0118 →
Continuity (2)
Provisional Application 6047240300 · May 22, 2003
Related Publication 20050014962A1 · Jan 20, 2005